Search

Type

Audience

Category

Issue

Last updated

Recall class

Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.

Displaying 1 - 15 of 55 items.

" " 99.0 % Oxygen USP - Gas cylinders containing commercial grade oxygen
Gas cylinders containing commercial grade oxygen instead of medical grade oxygen were delivered to homecare customers.
RecallHealth product recall | 2022-12-22
" " 18F-Fludeoxyglucose (18F-FDG); Sterility concerns
Product sterility may be compromised in the affected lot.
RecallHealth product recall | 2022-12-14
" " NAT-Bendamustine: Discoloration
The colour is out of specification in the affected lot(s).
RecallHealth product recall | 2022-12-06
" " Privigen: Series of adverse reactions
Affected lot being voluntarily recalled due to a series of adverse reactions.
RecallHealth product recall | 2022-12-01
" " Teva-Atenolol; Product label image incorrect
Affected lot has incorrect product image on the product label.
RecallHealth product recall | 2022-11-21
" " POTASSIUM CHLORIDE IN LACTATED RINGER'S INJECTION: Affected lot is labelled with the incorrect strength and ingredient
Affected lot is labelled with the incorrect strength and ingredient  
RecallHealth product recall | 2022-10-24
" " Menopur: Potential for a future out of specification result during shelf life
 Potential for a future out of specification result during shelf-life
RecallHealth product recall | 2022-09-28
" " Lumi Lash: Unlicensed product with ingredient on prescription drug list.
Product sold without market authorization (DIN) in Canada. All affected lots may contain bimatoprost, a prostaglandin analogue, which is listed on the prescription drug list.  Test results for Lot 20220331 found the product to contain bimatoprost.…
RecallHealth product recall | 2022-09-26
" " Riva-Oxazepam: Incorrect label (Riva-Oxazepam 30MG 500 tablets DIN00568414) may be appended to affected lots that contains: Riva-Oxazepam 15MG 500 tablets DIN00568406
Incorrect label (Riva-Oxazepam 30MG 500 tablets DIN00568414) may be appended to affected lots that contains: Riva-Oxazepam 15MG 500 tablets DIN00568406. 
RecallHealth product recall | 2022-09-22
" " Esomeprazole, Candesartan and Pravastatin Tablets: OOS result for Finished Product Assay and/or Blend Uniformity
Out of Specification result for Finished Product Assay and/or Blend Uniformity
RecallHealth product recall | 2022-09-21
" " Venlafaxine: OOS result for Spheroids Dissolution Rate Profile (DRP)
  Out of specification result for Spheroids Dissolution Rate Profile (DRP) 
RecallHealth product recall | 2022-09-21
" " Quetiapine 25 mg: The affected lot (quetiapine 25 mg) may contain sertraline 50 mg tablets.
The affected lot (quetiapine 25 mg) may contain sertraline 50 mg tablets.
RecallHealth product recall | 2022-09-02
" " Menopur: Out of specification (Assay)
Out of specification result for assay test in the affected lots
RecallHealth product recall | 2022-08-31
" " DRAXIMAGE MDP: Affected lot may contain particulate matter
Affected lot may contain particulate matter  
RecallHealth product recall | 2022-08-30
" " JAMP ATORVASTATIN CALCIUM: Affected lot may be labelled with the incorrect strength on the label.
Jamp Pharma Corporation is recalling one lot (D10776B) of Jamp-Atorvastatin Calcium after one bottle labelled to contain 10 mg tablets of Jamp-Atorvastatin Calcium was found to contain 40 mg tablets of Jamp-Atorvastatin Calcium. Pharmacists may not…
RecallHealth product recall | 2022-08-29
Report a problem or mistake on this page
What was wrong?

If you want to receive a follow-up reply, please include your name and e-mail address.

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.